David W. Hedley
Advanced in Cholangiocarcinoma (Bile Duct Cancer)

David W. Hedley

Toronto, ON, CA 
Advanced in Cholangiocarcinoma (Bile Duct Cancer)
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

David Hedley practices in Toronto, Canada. Mr. Hedley is rated as an Advanced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Cerebral Hypoxia, Pancreatic Ductal Adenocarcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Lung Transplant.

His clinical research consists of co-authoring 90 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Cholangiocarcinoma (Bile Duct Cancer).

Gender
Male

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Evaluation of Hypoxia Imaging in Patients With Pancreatic Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)
The Evaluation of Hypoxia Imaging in Patients With Pancreatic Cancer Using Positron Emission Tomography (PET) With 18F-Fluoroazomycin Arabinoside (18F-FAZA)
Enrollment Status: Completed
Publish Date: May 05, 2022
A Clinical Trial of Intratumoral Hypoxia and Its Biologic Correlates in Patients Undergoing Surgical Resection of Localized Pancreatic Cancer, Using Pre-operative Administration of the Hypoxia Marker Pimonidazole.
A Clinical Trial of Intratumoral Hypoxia and Its Biologic Correlates in Patients Undergoing Surgical Resection of Localized Pancreatic Cancer, Using Pre-operative Administration of the Hypoxia Marker Pimonidazole.
Enrollment Status: Completed
Publish Date: July 30, 2018
Intervention Type: Drug
View 1 Less Clinical Trial

90 Total Publications

Emergence of a senescent and inflammatory pulmonary CD4+ T cell population prior to lung allograft failure.
Emergence of a senescent and inflammatory pulmonary CD4+ T cell population prior to lung allograft failure.
Journal: Science advances
Published: March 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hedley's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile